The role of CD44 in disease pathophysiology and targeted treatment

Andre R. Jordan, Ronny R. Racine, Martin J.P. Hennig, Vinata B. Lokeshwar

Research output: Contribution to journalReview article

55 Citations (Scopus)

Abstract

The cell-surface glycoprotein CD44 is involved in a multitude of important physiological functions including cell proliferation, adhesion, migration, hematopoiesis, and lymphocyte activation. The diverse physiological activity of CD44 is manifested in the pathology of a number of diseases including cancer, arthritis, bacterial and viral infections, interstitial lung disease, vascular disease, and wound healing. This diversity in biological activity is conferred by both a variety of distinct CD44 isoforms generated through complex alternative splicing, posttranslational modifications (e.g., N- and O-glycosylation), interactions with a number of different ligands, and the abundance and spatial distribution of CD44 on the cell surface. The extracellular matrix glycosaminoglycan hyaluronic acid (HA) is the principle ligand of CD44. This review focuses both CD44-hyaluronan dependent and independent CD44 signaling and the role of CD44-HA interaction in various pathophysiologies. The review also discusses recent advances in novel treatment strategies that exploit the CD44-HA interaction either for direct targeting or for drug delivery.

Original languageEnglish (US)
Article number182
JournalFrontiers in immunology
Volume6
Issue numberAPR
DOIs
StatePublished - Jan 1 2015

Fingerprint

Hyaluronic Acid
Ligands
Biodiversity
Interstitial Lung Diseases
Membrane Glycoproteins
Hematopoiesis
Alternative Splicing
Virus Diseases
Therapeutics
Drug Delivery Systems
Post Translational Protein Processing
Lymphocyte Activation
Glycosaminoglycans
Glycosylation
Vascular Diseases
Bacterial Infections
Cell Adhesion
Wound Healing
Arthritis
Extracellular Matrix

Keywords

  • CD44
  • CD44-signaling
  • Hyaluronic acid
  • Hyaluronidase

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The role of CD44 in disease pathophysiology and targeted treatment. / Jordan, Andre R.; Racine, Ronny R.; Hennig, Martin J.P.; Lokeshwar, Vinata B.

In: Frontiers in immunology, Vol. 6, No. APR, 182, 01.01.2015.

Research output: Contribution to journalReview article

Jordan, Andre R. ; Racine, Ronny R. ; Hennig, Martin J.P. ; Lokeshwar, Vinata B. / The role of CD44 in disease pathophysiology and targeted treatment. In: Frontiers in immunology. 2015 ; Vol. 6, No. APR.
@article{e6fd993d50f24a74b7f9e27703ffd2c9,
title = "The role of CD44 in disease pathophysiology and targeted treatment",
abstract = "The cell-surface glycoprotein CD44 is involved in a multitude of important physiological functions including cell proliferation, adhesion, migration, hematopoiesis, and lymphocyte activation. The diverse physiological activity of CD44 is manifested in the pathology of a number of diseases including cancer, arthritis, bacterial and viral infections, interstitial lung disease, vascular disease, and wound healing. This diversity in biological activity is conferred by both a variety of distinct CD44 isoforms generated through complex alternative splicing, posttranslational modifications (e.g., N- and O-glycosylation), interactions with a number of different ligands, and the abundance and spatial distribution of CD44 on the cell surface. The extracellular matrix glycosaminoglycan hyaluronic acid (HA) is the principle ligand of CD44. This review focuses both CD44-hyaluronan dependent and independent CD44 signaling and the role of CD44-HA interaction in various pathophysiologies. The review also discusses recent advances in novel treatment strategies that exploit the CD44-HA interaction either for direct targeting or for drug delivery.",
keywords = "CD44, CD44-signaling, Hyaluronic acid, Hyaluronidase",
author = "Jordan, {Andre R.} and Racine, {Ronny R.} and Hennig, {Martin J.P.} and Lokeshwar, {Vinata B.}",
year = "2015",
month = "1",
day = "1",
doi = "10.3389/fimmu.2015.00182",
language = "English (US)",
volume = "6",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
number = "APR",

}

TY - JOUR

T1 - The role of CD44 in disease pathophysiology and targeted treatment

AU - Jordan, Andre R.

AU - Racine, Ronny R.

AU - Hennig, Martin J.P.

AU - Lokeshwar, Vinata B.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The cell-surface glycoprotein CD44 is involved in a multitude of important physiological functions including cell proliferation, adhesion, migration, hematopoiesis, and lymphocyte activation. The diverse physiological activity of CD44 is manifested in the pathology of a number of diseases including cancer, arthritis, bacterial and viral infections, interstitial lung disease, vascular disease, and wound healing. This diversity in biological activity is conferred by both a variety of distinct CD44 isoforms generated through complex alternative splicing, posttranslational modifications (e.g., N- and O-glycosylation), interactions with a number of different ligands, and the abundance and spatial distribution of CD44 on the cell surface. The extracellular matrix glycosaminoglycan hyaluronic acid (HA) is the principle ligand of CD44. This review focuses both CD44-hyaluronan dependent and independent CD44 signaling and the role of CD44-HA interaction in various pathophysiologies. The review also discusses recent advances in novel treatment strategies that exploit the CD44-HA interaction either for direct targeting or for drug delivery.

AB - The cell-surface glycoprotein CD44 is involved in a multitude of important physiological functions including cell proliferation, adhesion, migration, hematopoiesis, and lymphocyte activation. The diverse physiological activity of CD44 is manifested in the pathology of a number of diseases including cancer, arthritis, bacterial and viral infections, interstitial lung disease, vascular disease, and wound healing. This diversity in biological activity is conferred by both a variety of distinct CD44 isoforms generated through complex alternative splicing, posttranslational modifications (e.g., N- and O-glycosylation), interactions with a number of different ligands, and the abundance and spatial distribution of CD44 on the cell surface. The extracellular matrix glycosaminoglycan hyaluronic acid (HA) is the principle ligand of CD44. This review focuses both CD44-hyaluronan dependent and independent CD44 signaling and the role of CD44-HA interaction in various pathophysiologies. The review also discusses recent advances in novel treatment strategies that exploit the CD44-HA interaction either for direct targeting or for drug delivery.

KW - CD44

KW - CD44-signaling

KW - Hyaluronic acid

KW - Hyaluronidase

UR - http://www.scopus.com/inward/record.url?scp=84934278478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84934278478&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2015.00182

DO - 10.3389/fimmu.2015.00182

M3 - Review article

AN - SCOPUS:84934278478

VL - 6

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - APR

M1 - 182

ER -